BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27158065)

  • 1. Epidemiology of acromegaly in Ecuador.
    López Gavilanez E; Guerrero Franco K; Solórzano Zambrano N; Navarro Chávez M; López Estrella C; Vaca Burbano L; Marriott Díaz E
    Endocrinol Nutr; 2016; 63(7):333-8. PubMed ID: 27158065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of acromegaly in hospitalized patients with type 2 diabetes.
    Suda K; Fukuoka H; Iguchi G; Hirota Y; Nishizawa H; Bando H; Matsumoto R; Takahashi M; Sakaguchi K; Takahashi Y
    Endocr J; 2015; 62(1):53-9. PubMed ID: 25284247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acromegaly.
    Scacchi M; Cavagnini F
    Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Practical guidelines for diagnosis and treatment of acromegaly. Grupo de Neuroendocrinología de la Sociedad Española de Endocrinología y Nutrición].
    Cordido F; García Arnés JA; Marazuela Aspiroz M; Torres Vela E;
    Endocrinol Nutr; 2013 Oct; 60(8):457.e1-457.e15. PubMed ID: 23660006
    [No Abstract]   [Full Text] [Related]  

  • 5. [Epidemiology of acromegaly in Spain].
    Sesmilo G
    Endocrinol Nutr; 2013 Oct; 60(8):470-4. PubMed ID: 23246411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Micromegaly": an update on the prevalence of acromegaly with apparently normal GH secretion in the modern era.
    Butz LB; Sullivan SE; Chandler WF; Barkan AL
    Pituitary; 2016 Dec; 19(6):547-551. PubMed ID: 27497970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and prevalence of acromegaly in a large US health plan database.
    Burton T; Le Nestour E; Neary M; Ludlam WH
    Pituitary; 2016 Jun; 19(3):262-7. PubMed ID: 26792654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary tumours: acromegaly.
    Chanson P; Salenave S; Kamenicky P; Cazabat L; Young J
    Best Pract Res Clin Endocrinol Metab; 2009 Oct; 23(5):555-74. PubMed ID: 19945023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical GH Increase During OGTT Is Associated With First-Generation Somatostatin Analog Responsiveness in Acromegaly.
    Scaroni C; Albiger N; Daniele A; Dassie F; Romualdi C; Vazza G; Regazzo D; Ferraù F; Barresi V; Maffeis V; Gardiman MP; Cannavò S; Maffei P; Ceccato F; Losa M; Occhi G
    J Clin Endocrinol Metab; 2019 Mar; 104(3):856-862. PubMed ID: 30285115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acromegaly, a pituitary special issue.
    Fleseriu M; Gadelha M
    Pituitary; 2017 Feb; 20(1):2-3. PubMed ID: 28255899
    [No Abstract]   [Full Text] [Related]  

  • 11. Central Hypothyroidism Related to Pituitary Adenomas: Low Incidence of Central Hypothyroidism in Patients With Acromegaly.
    Takamizawa T; Horiguchi K; Nakajima Y; Okamura T; Ishida E; Matsumoto S; Yoshino S; Yamada E; Saitoh T; Ozawa A; Tosaka M; Yamada S; Yamada M
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4879-4888. PubMed ID: 31188431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic trends and outcome of acromegaly: a single center experience over a 40-year period.
    Karapanou O; Tzanela M; Christoforaki M; Papastathopoulou L; Moutsatsou P; Botoula E; Tsagarakis S
    Hormones (Athens); 2016 Jul; 15(3):368-376. PubMed ID: 27394702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and complications of neurosurgical treatment of acromegaly.
    Krzentowska-Korek A; Gołkowski F; Bałdys-Waligórska A; Hubalewska-Dydejczyk A
    Pituitary; 2011 Jun; 14(2):157-62. PubMed ID: 21107739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting long-term remission by measuring immediate postoperative growth hormone levels and oral glucose tolerance test in acromegaly.
    Kim EH; Oh MC; Lee EJ; Kim SH
    Neurosurgery; 2012 May; 70(5):1106-13; discussion 1113. PubMed ID: 22067418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in acromegaly at diagnosis: A nationwide cohort study and meta-analysis of the literature.
    Dal J; Skov BG; Andersen M; Feldt-Rasmussen U; Feltoft CL; Karmisholt J; Nielsen EH; Dekkers OM; Jørgensen JOL
    Clin Endocrinol (Oxf); 2021 Apr; 94(4):625-635. PubMed ID: 33306249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low insulin resistance after surgery predicts poor GH suppression one year after complete resection for acromegaly: a retrospective study.
    Edo N; Morita K; Suzuki H; Takeshita A; Miyakawa M; Fukuhara N; Nishioka H; Yamada S; Takeuchi Y
    Endocr J; 2016 May; 63(5):469-77. PubMed ID: 26949262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Not Available].
    Mosbah H; Brue T; Chanson P
    Ann Endocrinol (Paris); 2019 Sep; 80 Suppl 1():S10-S18. PubMed ID: 31606057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly.
    Carmichael JD; Bonert VS; Mirocha JM; Melmed S
    J Clin Endocrinol Metab; 2009 Feb; 94(2):523-7. PubMed ID: 19033371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Mexican Acromegaly Registry: Clinical and Biochemical Characteristics at Diagnosis and Therapeutic Outcomes.
    Portocarrero-Ortiz LA; Vergara-Lopez A; Vidrio-Velazquez M; Uribe-Diaz AM; García-Dominguez A; Reza-Albarrán AA; Cuevas-Ramos D; Melgar V; Talavera J; Rivera-Hernandez AJ; Valencia-Méndez CV; Mercado M;
    J Clin Endocrinol Metab; 2016 Nov; 101(11):3997-4004. PubMed ID: 27428551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current diagnosis and treatment of acromegaly].
    Melgar V; Espinosa E; Cuenca D; Valle V; Mercado M
    Rev Med Inst Mex Seguro Soc; 2015; 53(1):74-83. PubMed ID: 25680646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.